已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Abstract 3090:In vivocharacterization of AMG 510 - a potent and selective KRASG12Ccovalent small molecule inhibitor in preclinical KRASG12Ccancer models

作者
Karen Rex,Anne Y. Saiki,Ji-Rong Sun,Tyler Holt,Neelima Koppada,Brian A. Lanman,Laurie P. Volak,R. Foti,Victor J. Cee,James Russell Lipford,Jude R. Canon
出处
期刊:Experimental and Molecular Therapeutics 卷期号:: 3090-3090 被引量:1
标识
DOI:10.1158/1538-7445.sabcs18-3090
摘要

Somatic activating mutations of RAS family members are tumor driver mutations found in an estimated 21% of all cancers. Oncogenic KRAS mutations at residues G12, G13, and Q61 represent the most common RAS mutations found in solid malignancies. The prevalence of KRAS p.G12C tumors is ~13% of lung adenocarcinoma (including NSCLC), 3% of colorectal carcinoma (CRC), and 1% to 2% of numerous other solid tumors, representing an unmet medical need. We have developed AMG 510, an orally bioavailable, covalent inhibitor of KRASG12C with potent biochemical and cellular activity, and robust in vivo efficacy. AMG 510 inhibited SOS-catalyzed nucleotide exchange of recombinant mutant KRASG12C/C118A but had minimal effect on KRASC118A, which is wildtype at position 12. In cellular assays, AMG 510 covalently modified KRASG12C and inhibited KRASG12C signaling as measured by phosphorylation of ERK1/2 (p-ERK) in all KRAS p.G12C-mutant cell lines tested but did not inhibit p-ERK in cell lines with various other KRAS mutations. AMG 510 also selectively impaired viability of KRAS p.G12C mutant cell lines but did not affect cell lines with other KRAS mutations. In vivo pharmacodynamic assays demonstrated dose- and time-dependent inhibition of KRASG12Csignaling in human pancreatic and NSCLC tumor xenografts. Covalent modification of KRASG12C by AMG 510 was measured by mass spectrometry and correlated with p-ERK inhibition in tumors. AMG 510 significantly inhibited the growth of KRAS p.G12C xenografts and resulted in tumor regression. Combination treatment of AMG 510 with standard-of-care and targeted agents demonstrated enhanced tumor growth inhibition compared to either single agent. In a syngeneic model of KRAS p.G12C mutant cancer, AMG 510 treatment significantly inhibited tumor growth and caused regression. AMG 510 is currently in Phase 1, first-in-human clinical trials for patients with advanced solid tumors harboring a KRAS p.G12C mutation.Citation Format: Karen Rex, Anne Y. Saiki, Ji-Rong Sun, Tyler Holt, Neelima Koppada, Brian A. Lanman, Laurie P. Volak, Robert S. Foti, Victor J. Cee, J. Russell Lipford, Jude Canon. In vivo characterization of AMG 510 - a potent and selective KRASG12Ccovalent small molecule inhibitor in preclinical KRASG12Ccancer models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 3090.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
十二完成签到 ,获得积分10
1秒前
影月cindy的应助被那个大好人采纳,获得10
1秒前
2秒前
萧衡完成签到 ,获得积分10
2秒前
天灵灵完成签到,获得积分10
3秒前
Mabor完成签到 ,获得积分10
4秒前
Spark完成签到,获得积分10
7秒前
molihuakai的应助被ww_采纳,获得10
8秒前
健壮绮彤发布了新的文献求助10
8秒前
10秒前
10秒前
10秒前
12秒前
初景的应助被Psy_ru采纳,获得20
13秒前
14秒前
16秒前
阿泽完成签到,获得积分10
16秒前
18秒前
傅jh完成签到,获得积分10
19秒前
19秒前
小龙长眠完成签到 ,获得积分10
19秒前
20秒前
Leoones发布了新的文献求助10
21秒前
鹰隼游发布了新的文献求助10
21秒前
Jeffery完成签到,获得积分10
23秒前
23秒前
hitzwd完成签到,获得积分0
23秒前
GLORY完成签到,获得积分10
24秒前
卡恩完成签到 ,获得积分0
24秒前
ultrasound11001完成签到,获得积分10
25秒前
Jeffery发布了新的文献求助10
25秒前
wanci的应助被土豆采纳,获得10
26秒前
26秒前
GLORY发布了新的文献求助10
27秒前
ofafafa完成签到 ,获得积分10
27秒前
27秒前
27秒前
momo完成签到 ,获得积分10
28秒前
29秒前
七月完成签到 ,获得积分10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194689
求助须知:如何正确求助?哪些是违规求助? 9580456
关于积分的说明 21871058
捐赠科研通 7794234
什么是DOI,文献DOI怎么找? 3437711
关于科研通互助平台的介绍 2561001
邀请新用户注册赠送积分活动 2484417